Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Hospira Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (283)
Cancellation by sponsor (53)

Date

2025 (8)
2024 (12)
2023 (7)
2022 (9)
2021 (30)
2020 (31)
2019 (28)
2018 (1)
2017 (5)
2016 (5)
2015 (4)
2014 (7)
2013 (14)
2012 (1)
2011 (10)
2010 (2)
2009 (16)
2008 (23)
2007 (61)
2006 (7)
2005 (23)
2004 (9)
2001 (2)
2000 (2)
1998 (3)
1997 (4)
1996 (1)
1994 (4)
1992 (4)
1991 (3)

Search

Sponsor content

336 result(s) found, displaying 171 to 180

DBL GABAPENTIN gabapentin 300mg capsule blister pack Cancelled under s30(1)(c )

23 July 2014

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL GABAPENTIN gabapentin 400mg capsule blister pack Cancelled under s30(1)(c )

23 July 2014

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Nipent (Pentostatin for Injection) 10 mg (171028)

4 May 2010

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Nipent (Pentostatin for Injection) 10 mg.
Hospira Nipent (pentostatin for injection) 10 mg US (171027)

4 May 2010

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Nipent (pentostatin for injection) 10 mg US.
Hospira Gemcitabine for Injection 200 mg/vial (164138)

6 August 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine for Injection 200 mg/vial.
Hospira Gemcitabine for Injection 2 g/vial (164137)

6 August 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine for Injection 2 g/vial.
Hospira Gemcitabine for Injection 1g/vial (164139)

6 August 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine for Injection 1g/vial.
Hospira Gemcitabine 1g Powder for solution for Infusion (163248)

10 July 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine 1g Powder for solution for Infusion.
Hospira Gemcitabine 2 g Powder for Solution for Infusion (163247)

10 July 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine 2 g Powder for Solution for Infusion.
Hospira Gemcitabine 200 mg Powder for Solution for Infusion (163246)

10 July 2009

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Gemcitabine 200 mg Powder for Solution for Infusion.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.